Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD)
- 2.6k Downloads
Glucose is a major energy source for the entire body, while fructose metabolism occurs mainly in the liver. Fructose consumption has increased over the last decade globally and is suspected to contribute to the increased incidence of non-alcoholic fatty liver disease (NAFLD). NAFLD is a manifestation of metabolic syndrome affecting about one-third of the population worldwide and has progressive pathological potential for liver cirrhosis and cancer through non-alcoholic steatohepatitis (NASH). Here we have reviewed the possible contribution of fructose to the pathophysiology of NAFLD. We critically summarize the current findings about several regulators, and their potential mechanisms, that have been studied in humans and animal models in response to fructose exposure. A novel hypothesis on fructose-dependent perturbation of liver regeneration and metabolism is advanced. Fructose intake could affect inflammatory and metabolic processes, liver function, gut microbiota, and portal endotoxin influx. The role of the brain in controlling fructose ingestion and the subsequent development of NAFLD is highlighted. Although the importance for fructose (over)consumption for NAFLD in humans is still debated and comprehensive intervention studies are invited, understanding of how fructose intake can favor these pathological processes is crucial for the development of appropriate noninvasive diagnostic and therapeutic approaches to detect and treat these metabolic effects. Still, lifestyle modification, to lessen the consumption of fructose-containing products, and physical exercise are major measures against NAFLD. Finally, promising drugs against fructose-induced insulin resistance and hepatic dysfunction that are emerging from studies in rodents are reviewed, but need further validation in human patients.
KeywordsInsulin resistance Inflammation Metabolic syndrome (MetS) Gut microbiota Herbal medicine Biomarkers The brain Ethanol Humans Oxidative stress Liver regeneration ATP
Cytochrome 450 2E1
High-fructose corn syrup
Insulin receptor substrate 1/2
Melanocortin receptor 4
Non-alcoholic fatty liver disease
Plasminogen activator inhibitor-1
Reactive oxygen species
Type 2 diabetes mellitus
Toll-like receptor 4
Tumor necrosis factor-α
S.M.A. and R.G. conceived, designed, wrote, and approved the final manuscript. The authors thank Dr. John Hallett, MCR Centre for Regenerative Medicine, The University of Edinburgh, UK, for proofreading the paper.
This study was supported by grants from the Bundesministerium für Forschung und Technologie (BMBF) in the framework of the Systems Biology initiative “Virtual Liver Network” to RG (Grant: 0315735).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- Aroor AR, Habibi J, Ford DA et al (2015) Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function. Diabetes 64:1988–2001. doi: 10.2337/db14-0804 PubMedPubMedCentralCrossRefGoogle Scholar
- Bettaieb A, Vazquez Prieto MA, Rodriguez Lanzi C et al (2014) (−)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress. Free Radic Biol Med 72:247–256. doi: 10.1016/j.freeradbiomed.2014.04.011 PubMedPubMedCentralCrossRefGoogle Scholar
- Borkham-Kamphorst E, Drews F, Weiskirchen R (2011) Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation. Liver Int 31:656–665. doi: 10.1111/j.1478-3231.2011.02495.x PubMedCrossRefGoogle Scholar
- Bray GA, Nielsen SJ, Popkin BM (2004) Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 89:537–543Google Scholar
- Charlton M, Krishnan A, Viker K et al (2011) Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am J Physiol Gastrointest Liver Physiol 301:G825–G834. doi: 10.1152/ajpgi.00145.2011 PubMedPubMedCentralCrossRefGoogle Scholar
- Clayton ZE, Vickers MH, Bernal A et al (2015) Early life exposure to fructose alters maternal, fetal and neonatal hepatic gene expression and leads to sex-dependent changes in lipid metabolism in rat offspring. PLoS ONE 10:e0141962. doi: 10.1371/journal.pone.0141962 PubMedPubMedCentralCrossRefGoogle Scholar
- Cox CL, Stanhope KL, Schwarz JM et al (2012) Consumption of fructose—but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans. Nutr Metab 9:68. doi: 10.1186/1743-7075-9-68 CrossRefGoogle Scholar
- Downing LE, Heidker RM, Caiozzi GC et al (2015) A grape seed procyanidin extract ameliorates fructose-induced hypertriglyceridemia in rats via enhanced fecal bile acid and cholesterol excretion and inhibition of hepatic lipogenesis. PLoS ONE 10:e0140267. doi: 10.1371/journal.pone.0140267 PubMedPubMedCentralCrossRefGoogle Scholar
- Lanaspa MA, Sanchez-Lozada LG, Choi YJ et al (2012b) Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: Potential role in fructose-dependent and -independent fatty liver. J Biol Chem 287:40732–40744. doi: 10.1074/jbc.M112.399899 PubMedPubMedCentralCrossRefGoogle Scholar
- Mortensen OH, Larsen LH, Ørstrup LKH et al (2014) Developmental programming by high fructose decreases phosphorylation efficiency in aging offspring brain mitochondria, correlating with enhanced UCP5 expression. J Cereb Blood Flow Metab 34:1205–1211. doi: 10.1038/jcbfm.2014.72 PubMedPubMedCentralCrossRefGoogle Scholar
- Renaud HJ, Cui JY, Lu H, Klaassen CD (2014) Effect of diet on expression of genes involved in lipid metabolism, oxidative stress, and inflammation in mouse liver-insights into mechanisms of hepatic steatosis. PLoS ONE 9:e88584. doi: 10.1371/journal.pone.0088584 PubMedPubMedCentralCrossRefGoogle Scholar
- Spruss A, Henkel J, Kanuri G et al (2012a) Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response. Mol Med 18:1346–1355. doi: 10.2119/molmed.2012.00223 PubMedPubMedCentralCrossRefGoogle Scholar
- Stanhope KL, Schwarz JM, Keim NL et al (2009) Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 119:1322–1334. doi: 10.1172/JCI37385 PubMedPubMedCentralCrossRefGoogle Scholar